volume 26, issue 4, P225-235 2013
DOI: 10.1155/2013/902016
View full text
Hajar Alobaidi, Hardev Pall

Abstract: Abstract. Objectives:The pharmacotherapy of Parkinson's disease (PD) is often challenging as clinicians have to find a favourable balance between the efficacy on motor symptoms and side effect profiles of different dopaminergic medications. We aimed to assess the available evidence on the role of dopamine agonist monotherapy as an alternative to Levodopa in the treatment of motor symptoms of PD, along with the role of dopamine antagonists in the treatment of PD-related psychosis. Methods: We performed a syste…

expand abstract